IBD Essentials

Recent BSGE guidelines of chromoendoscopy

Pradeep Bhandari from Portsmouth (UK) on recent BSGE guidelines of chromoendoscopy, co-hosted by Raf Bisschops.

Recent clinical trial results informing clinical decision making for vedolizumab and anti-IL23 therapies

Dr. Remo Panaccione, an internationally recognized expert in clinical trials discusses the recent data on vedolizumab and anti-IL23 therapies and how those changes impact clinical decision making in IBD

Relevance of cell-based therapies in IBD including hematopoetic stem cell transplantation and CAR T cell therapies

Matthieu Allez, Montreal talks about cell-based therapeutic approaches in refractory or complicated IBD covering hematopoetic stem cell transplantation and CAR T cell therapies, indication for this treatment options, success rates and potential side effects and potential future approaches

Discussion about the role of B cells in health and other autoimmune diseases with highlighting the recent groundbreaking observations of B cell directed CART cell therapy in IBD

Dr. Saurabh Mehandru, Mount Sinai Hospital in New York, internationally recognized physician scientist in IBD and global leader in B cell biology in intestinal health and inflammation discussed the role of B cells in intestinal homeostasis and IBD. Highliy relevant episode about a novel therapy that is entering IBD.

Introduction of Ailsa Hart as Co-Host of IBD Essentials and Management of Perianal Crohn's disease

Ailsa Hart, St. Marks Hospital, London, UK, internationally renowned IBD expert talks about strategies to optimize the management of perianal fistulising Crohn's disease, relevance of MDT approaches, building international consortia, classification and optimized management of perianal fistulising CD